The aim of the study, therefore, is to determine whether exogenous administration of nociceptin will have any acute impact on the tissue expression of selected endogenous antioxidants (catalase, superoxide dismutase, glutathione reductase) in the kidney, liver, and brain of rats after the onset of diabetes mellitus. The gene discussed is CAT; the disease is diabetes mellitus.